National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Research
 Research by Topic
 Research Resources
  Clinical Research Toolkit
  DAIDS Clinical Research Policies
   Comment Period for New DAIDS Policies
   About
   Protocol and Informed Consent
   Clinical Site
   Safety
   Laboratories
   Regulatory
   Pharmacy
   Data Management and Statistics
   Glossary
   Frequently Asked Questions
  DMID Clinical Research Policies
  DMID Services for Researchers
  HIV/AIDS Specimen Repository
  Rabbit Immunology


Comment Period for New DAIDS Policies

DAIDS is happy to announce that three new policies are now available for comment. The following links policies and associated appendices:

  1. Storage and Retention of Clinical Research Records (PDF)
  2. Enrolling Children (including Adolescents) in DAIDS-Funded and/or Sponsored Human Subject Clinical Research: Clinical Research Site Requirements (PDF)
  3. Enrolling Children (including Adolescents) in DAIDS-Funded and/or Sponsored Human Subject Clinical Research: Protocol Document Requirements (PDF)

Comments may be submitted to NIAIDOPCROPOLICYGROUP@mail.nih.gov. Please include the name of the document (Policy/Appendices), and line number(s) that correspond to your comments.

The comment period will be open until October 24, 2008.

About Division of AIDS (DAIDS) Clinical Research Policies and Standard Procedures Documents
 
Introduction

A robust set of policies and procedures is essential to a clinical research enterprise. In this regard, the Division of AIDS (DAIDS) has recently standardized and updated our Clinical Research Policies and Standard Procedures. Accordingly, all human subjects research funded and/or sponsored by DAIDS must be compliant with these policies and standard procedures in addition to the NIAID Clinical Terms of Award and all NIH clinical research policies.

Status of DAIDS Policies and Standard Procedures Documents

DAIDS has collated the comments received from its networks and other stakeholders and made appropriate revisions to finalize the documents. The versions now posted are final.  

Compliance

By June 1, 2008, DAIDS may, at its discretion, request the Clinical Site Monitoring Group (CSMG) monitors to spot-check training documentation for compliance during monitoring visits. Also, appropriate HSP/GCP training documentation for key personnel will be submitted with progress reports for review by the Program Officer.

Scope

The applicability of each policy and standard procedure to different types of research (i.e., human subjects research or clinical trial) is outlined in the document’s statement of Scope and is listed in the Table of Research Applicability.

For More Information

For questions regarding specific policies and standard procedures, contact the DAIDS Policy Group.

See Also

Division of Acquired Immunodeficiency Syndrome

Investigator-Initiated Clinical Trial Planning and Implementation Grants

Search in Research
 
E-mail Icon E-mail this page
Print Icon Print this page

See Also

Division of Acquired Immunodeficiency Syndrome

Investigator-Initiated Clinical Trial Planning and Implementation Grants